PRL3-zumab as an immunotherapy to inhibit tumors expressing PRL3 oncoprotein (vol 10, 2484, 2019)

• Main Authors: Thura, Min, Al-Aidaroos, Abdul Qader, Gupta, Abhishek, Chee, Cheng Ean, Lee, Soo Chin, Hui, Kam Man, Li, Jie, Guan, Yeoh Khay, Yong, Wei Peng, So, Jimmy, Chng, Wee Joo, Ng, Chin Hin, Zhou, Jianbiao, Wang, Ling Zhi, Yuen, John Shyi Peng, Ho, Henry Sun Sien, Yi, Sim Mei, Chiong, Edmund, Choo, Su Pin, Ngeow, Joanne, Ng, Matthew Chau Hsien, Chua, Clarinda, Yeo, Eugene Shen Ann, Tan, Iain Bee Huat, Sng, Joel Xuan En, Tan, Nicholas Yan Zhi, Thiery, Jean Paul, Goh, Boon Cher, Zeng, Qi
• Other Authors: CANCER SCIENCE INSTITUTE OF SINGAPORE
• Format: Article
• Language: English
• Published: NATURE PORTFOLIO 2021
• Subjects: Science & Technology; Multidisciplinary Sciences; Science & Technology - Other Topics
• Online Access: https://scholarbank.nus.edu.sg/handle/10635/208517
• Institution: National University of Singapore

10.1038/s41467-021-26548-6